LetsGetChecked

Truepill is a B2B pharmacy fulfillment service headquartered in San Mateo, California. Founded in 2016 by Umar Afridi and Sid Viswanathan, the company provides a pharmacy API and medication fulfillment to customers across all 50 states from its own facilities. Truepill collaborates with direct-to-consumer brands, digital health companies, and various healthcare organizations to enhance the pharmacy experience. Its technology offers real-time visibility into patients, prescriptions, and order details, facilitating payment flexibility and delivery tracking. With a team of 150 employees, Truepill has attracted investment from several notable investors, including Initialized Capital and Y Combinator.

Veritas Intercontinental, S.L., founded in 2004 and based in Madrid, Spain, specializes in whole genome sequencing and genetic testing services. The company provides a range of tests, including myGenome, which assesses risks for hereditary diseases and medication responses; myNewbornDNA, which offers insights into genetic diseases in newborns; myCancerRiskDNA, focused on cancer risk assessment; and myDiagnostic for those showing symptoms of hereditary genetic conditions. Veritas aims to empower individuals to enhance their health and longevity through actionable genetic information. It was established to extend the availability of whole genome sequencing beyond the United States and has garnered recognition from leading technology and health organizations for its innovations and contributions to the field of genomics.

Veritas Genetics International Ltd. is a genetic testing service provider based in Danvers, Massachusetts, with operations across North America, Asia, and Europe. The company collaborates with scientists, physicians, advisors, and patient advocates to develop and deliver innovative genetic testing solutions. Veritas Genetics utilizes advanced genetic technology that can identify a broader spectrum of gene variations than conventional next-generation sequencing methods. Among its offerings, the company provides a screening test for hereditary breast and ovarian cancer risk, facilitating informed decision-making for clinical researchers and healthcare providers. Through its services, Veritas Genetics aims to empower individuals to lead healthier and longer lives.

BioIQ, founded in 2005 and based in Atlanta, Georgia, is a health improvement technology company focused on enhancing corporate health and wellness programs. It offers a unique health screening platform and an ecosystem of tools designed to provide quantifiable wellness insights. BioIQ's solutions include humanized analytics, omnichannel communications, and care navigation services for health plans, employers, and government entities. The company collaborates with major employers and health companies across the United States, having successfully launched over 3,000 health improvement programs.